Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Correlation between ECG and Cardiac Cycle01:25

Correlation between ECG and Cardiac Cycle

11.3K
The electrical signals recorded on an electrocardiogram (ECG) occur before the mechanical processes of contraction and relaxation during the cardiac cycle.
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
11.3K
Pulse rhythm01:30

Pulse rhythm

1.2K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

304
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
304

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Craniometaphyseal Dysplasia: A Multidisciplinary Approach and Orthognathic Management in an Adolescent Patient.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2026
Same author

The mitochondrial protease, LonP1, is a potential cardioprotective target for attenuating doxorubicin-induced cardiomyocyte death.

Journal of translational medicine·2026
Same author

Heterogeneity in proportional cardiovascular co-listing on cancer death certificates in the United States: a national multiple cause-of-death analysis, 1999-2020.

Cardio-oncology (London, England)·2026
Same author

Advances in machine learning for cardiac event prediction: where can we still improve?

Expert review of cardiovascular therapy·2026
Same author

Trabectedin-Associated Myocardial Infarction With Nonobstructive Coronary Arteries.

JACC. Case reports·2026
Same author

Performance of Traditional Cardiovascular Risk Scores and Objective Optimization in Cancer Survivors.

Current oncology (Toronto, Ont.)·2026

Related Experiment Video

Updated: Dec 28, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Machine learning for predicting cardiac events: what does the future hold?

Brijesh Patel1, Partho Sengupta1

  • 1Heart and Vascular Institute, West Virginia University, Morgantown, WV, USA.

Expert Review of Cardiovascular Therapy
|February 19, 2020
PubMed
Summary
This summary is machine-generated.

Machine learning (ML) models outperform traditional statistical methods for predicting cardiovascular events (CVEs). ML offers individualized risk assessment, crucial for managing increasing cardiovascular disease burdens.

Keywords:
Machine Learningartificial intelligencecardiovascular eventsprediction

More Related Videos

Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

822
Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
06:07

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

4.2K

Related Experiment Videos

Last Updated: Dec 28, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

822
Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
06:07

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

4.2K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Artificial Intelligence in Medicine

Background:

  • Cardiovascular diseases (CVDs) represent a growing global health concern, necessitating improved risk prediction.
  • Existing statistical models for cardiovascular events (CVEs) often lack precision at the individual patient level.
  • Machine learning (ML) offers advanced capabilities for analyzing complex datasets and enhancing individual risk stratification.

Purpose of the Study:

  • To review and compare the performance of ML methods against traditional statistical models for predicting CVEs.
  • To summarize key ML techniques applicable to cardiovascular risk prediction.
  • To discuss the application of ML in predicting specific CVEs, including major adverse cardiovascular events, heart failure, and arrhythmias.

Main Methods:

  • Literature review comparing ML models with statistical models for CVE prediction.
  • Summary of fundamental ML algorithms relevant to medical risk prediction.
  • Analysis of studies focusing on ML applications for major adverse cardiovascular events, heart failure, and arrhythmias.

Main Results:

  • Evidence indicates ML methods generally outperform statistical models in predicting CVEs.
  • ML models demonstrate superior ability in providing individualized risk predictions compared to population-level statistical models.
  • Statistical models are prone to overfitting, whereas ML methods can capture complex patterns for personalized risk assessment.

Conclusions:

  • ML methods are superior to traditional statistical models for predicting cardiovascular events.
  • ML enables personalized risk assessment, a significant advantage over population-based statistical approaches.
  • Future research should focus on prospective studies evaluating ML-guided interventions for CVE prevention.